Using the Inactive Ingredient Database Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 11, 2019
May 6, 2020
0bf5000a-4dfb-4c0c-b619-fdb0e028ed1d
Related Documents
Establishing Impurity Specifications for Antibiotics
Guidance DocumentApril 20, 2026Center for Drug Evaluation and Research
Microbiological Quality Considerations in Non-Sterile Drug Manufacturing: Draft Guidance for Industry
Guidance DocumentSeptember 29, 2021Center for Drug Evaluation and Research
How To Obtain a Covered Product Authorization
Guidance DocumentSeptember 21, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox